In vitro and in vivo evaluation of cysteine rebridged trastuzumab–MMAE antibody drug conjugates with defined drug-to-antibody ratios

P Bryant, M Pabst, G Badescu, M Bird… - Molecular …, 2015 - ACS Publications
The conjugation of monomethyl auristatin E (MMAE) to trastuzumab using a reduction bis-
alkylation approach that is capable of rebridging reduced (native) antibody interchain …
被引用次数：140 相关文章

In vitro and in vivo evaluation of cysteine rebridged trastuzumab-MMAE antibody drug conjugates with defined drug-to-antibody ratios

P Bryant, M Pabst, G Badescu, M Bird… - Molecular …, 2015 - research.tudelft.nl
The conjugation of monomethyl auristatin E (MMAE) to trastuzumab using a reduction bis-
alkylation approach that is capable of rebridging reduced (native) antibody interchain …

[引用][C] In Vitro and In Vivo Evaluation of Cysteine Rebridged Trastuzumab–MMAE Antibody Drug Conjugates with Defined Drug-to-Antibody Ratios

P Bryant, M Pabst, G Badescu, M Bird… - Molecular …, 2015 - cir.nii.ac.jp
In Vitro and In Vivo Evaluation of Cysteine Rebridged Trastuzumab–MMAE Antibody Drug
Conjugates with Defined Drug-to-Antibody Ratios | CiNii Research CiNii 国立情報学研究所 学術 …

In Vitro and In Vivo Evaluation of Cysteine Rebridged Trastuzumab-MMAE Antibody Drug Conjugates with Defined Drug-to-Antibody Ratios

P Bryant, M Pabst, G Badescu, M Bird… - Molecular …, 2015 - pubmed.ncbi.nlm.nih.gov
The conjugation of monomethyl auristatin E (MMAE) to trastuzumab using a reduction bis-
alkylation approach that is capable of rebridging reduced (native) antibody interchain …

In Vitro and In Vivo Evaluation of Cysteine Rebridged Trastuzumab-MMAE Antibody Drug Conjugates with Defined Drug-to-Antibody Ratios.

P Bryant, M Pabst, G Badescu, M Bird… - Molecular …, 2015 - europepmc.org
The conjugation of monomethyl auristatin E (MMAE) to trastuzumab using a reduction bis-
alkylation approach that is capable of rebridging reduced (native) antibody interchain …